Replies to post #1418 on Precious Metals

[bladerunner1717]

>> HGEN <<


I had HGEN on my radar screen over the summer (loosely), but decided against Covid plays in general, and then HGEN did a reverse split ~Sept and I lost interest. But as you said, they do have a non-Covid pipeline and a good cash position. There was an I-Hub poster involved in bio research who liked the stock, which is how I heard about it.

Looks like Covid has been an expensive distraction for a lot of bio companies, but some also used it as a way to lift their stock price and raise money. The reverse split (which scared me off) also served to clean up HGEN's share structure, which is now down to 51 mil outstanding, per Yahoo, which restores their ability to raise more money. More often a reverse split is a signal to get out of a stock, but there are always exceptions.

Agree with you on HGEN. I think a drug which can alleviate the effects of cytokine storm would be useful far beyond COVIS-19. I'm also betting on management.

Yeah, did very well on CCXI. Got in at $7.


Bladerunner